 |
|
|
| |
Pharmacokinetic Interactions Between Antiretroviral Agents and the Investigational HCV Protease Inhibitor Telaprevir in Healthy Volunteers
|
| |
| |
Reported by Jules Levin
CROI Boston March 1 2011
R van Heeswijk,1 A Vandevoorde,1 G Boogaerts,1 T Vangeneugden,1 E de Paepe,1 R Polo,1 R Van Solingen-Ristea,1 K de Backer,1 V Garg,2 and M Beumont1
1Tibotec BVBA, Beerse, Belgium; 2Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA
|
| |
|
|
|
|
|
